- Citations, last 5 years
- 5
- Works, last 5 years
- 1
- h-index
- 12
- Scientists listed
- 0
- Grants since 2016
- 1
Grants received
2016–2018 · research · R44
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
Isabel Kurth · RGenix (United States) · funded by National Institutes of Health